Variable | Category | Included in the analysis (n=432), n (col %) |
Sociodemographic characteristics | ||
Age category | ||
35–54 | 151 (35) | |
25–34 | 237 (55) | |
18–24 | 44 (10) | |
Level of education | ||
No education | 40 (9) | |
Primary | 251 (58) | |
Secondary and above | 141 (33) | |
Religion | ||
Christian | 333 (77) | |
Muslim | 99 (23) | |
Marital status | ||
Married | 19 (4) | |
Widowed | 47 (11) | |
Divorced/Separated | 288 (67) | |
Never married | 78 (18) | |
Source of income | ||
Other in addition to sex work | 227 (53) | |
Sex work only | 205 (47) | |
Violence experience in the last 3 months | ||
Yes | 148 (34) | |
No | 284 (66) | |
Alcohol use | ||
Low risk | 188 (44) | |
Harmful/High risk | 182 (42) | |
Alcohol-dependent | 62 (14) | |
Sexual behavioural characteristics | ||
Condom use at last sexual intercourse | ||
Yes | 259 (60) | |
No | 173 (40) | |
Lifetime sexual partners | ||
<50 | 77 (18) | |
≥50 | 345 (80) | |
Missing | 10 (2) | |
Participants’ clinical characteristics | ||
Baseline CD4+ T-cell counts | ||
≤350 | 187 (43) | |
>350 | 245 (57) | |
WHO stage | ||
Stage I | 265 (61) | |
Stage II | 82 (19) | |
Stages III and IV | 37 (9) | |
Missing | 48 (11) | |
Place of ART initiation | ||
Clinic-initiated | 374 (87) | |
Transfer-in | 58 (13) | |
ART regimen | ||
First-line | ||
AZT-3TC-EFV AZT-3TC-NVP TDF-3TC-EFV TDF-3TC-NVP | 5 (1) 17 (4) 378 (88) 22 (5) | |
Second-line TDF-3TC-LPV/r TDF-3TC-ATV/r AZT-3TC-ATV/r | 3 (1) 6 (1) 1 (0) | |
Adherence status | ||
Adherent | 359 (83) | |
Non-adherent | 73 (17) | |
Duration on ART (years) | Median (IQR) | 2.3 (1.8–3.2) |
Baseline CD4+ T-cell count | Median (IQR) | 395 (248–597) |
Criteria for ART initiation | ||
CD4 ≤350 cells/mm3 | 171 (40) | |
Test and treat | 261 (60) |
ART, antiretroviral therapy; ATV/r, Atazanavir/Ritonavir; AZT, zidovudine; EFV, efavirenz; FSWs, female sex workers; LPV/r, Lopinavir/Ritonavir; NVP, nevirapine; 3TC, lamivudine; TDF, tenofovir.